We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Horizon Pharma Snaps Up Gout Drugmaker for $510 Million to Expand Orphan Drug Portfolio
Horizon Pharma Snaps Up Gout Drugmaker for $510 Million to Expand Orphan Drug Portfolio
Horizon Pharma has acquired Lake Forest, Ill.-based Crealta Holdings for $510 million in cash, in a deal that expands Horizon’s orphan drug business, the Irish firm said Friday.